Our results indicate that CD151-α3β1 integrin complexes suppress ovarian cancer malignancy largely by counteracting EMT-like processes as well as inhibiting Slug activation and canonical Wnt signaling. The gene discussed is SNAI2; the disease is ovarian cancer.